Arcellx, Inc. (NASDAQ:ACLX) Accelerates Toward Gilead Acquisition, Near-Term Integration Likely
Acquisition headlines and insider activity have shifted the company’s immediate profile; fundamentals still show heavy R&D burn and WMDST maintains an over-valued classification. Technical momentum and near-term catalysts create a narrow window for directional movement ahead of the transaction close.








